NHS :: Doctors’ contracts not to blame for NHS debt, says BMA
New contracts for consultants and GPs are not to blame for NHS debts, says the BMA in its response to the Public Accounts Committee (PAC) report on financial management in the NHS.
Management
Diabetes :: Delta Burke to Americans – Let’s Talk about Managing Diabetes
Stage, screen and film actress Delta Burke is leading the BYETTA Let’s Talk campaign, sponsored by Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) and Eli Lilly and Company (NYSE: LLY).
Depression :: Duloxetine reduced non-specific pain and emotional symptoms with depression
The antidepressant duloxetine, at a once-daily dose of 60 mg, significantly reduced non-specific pain and emotional symptoms associated with depression in a new, eight-week, placebo-controlled study of 327 adult patients with at least moderate pain and major depression. The results were presented today at the 15th European Congress of Psychiatry (AEP) in Madrid, Spain.
Pharmaceutical :: Novartis ranked No. 1 among pharmaceutical companies in Fortune magazine
Novartis has been ranked as the No. 1 company worldwide in the pharmaceuticals industry in the latest peer group results of the annual Fortune magazine survey of the “World’s Most Admired Companies.”
Food :: Alternative temperature-indicating devices for processing low-acid canned foods
The Food and Drug Administration (FDA) issued a proposed rule which, if finalized, would benefit both consumers and the food industry by enabling manufacturers of heat-processed low-acid canned foods to modernize their equipment by using alternative temperature-indicating devices (TIDs).
Blood Disorder :: FDA approves first-of-its-kind drug to treat rare blood disorder
The U.S. Food and Drug Administration (FDA) approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death. Soliris is classified as an Orphan Drug and is a new molecular entity containing an ingredient not previously marketed in the United States.
Nanotechnology :: Nanotechnology oversight requires thinking outside the box
With hundreds of nanotechnology-enabled products already on the market and many more in the commercial pipeline, a new report by a former senior Environmental Protection Agency official urges policymakers to give greater attention to the challenges of crafting an oversight system that can effectively address health and safety issues particular to nanoscale materials and devices.
Medicaid :: Pregnancy complications account for majority of Emergency Medicaid costs for undocumented immigrants
A large majority of the Emergency Medicaid expenditures in North Carolina are for childbirth and complications of pregnancy for patients who are undocumented immigrants, although spending for undocumented elderly and disabled patients is increasing at a faster rate, according to a study in the March 14 issue of JAMA, a theme issue on access to care.
Childbirth :: Emergency Medicaid for immigrants goes to childbirth
An analysis of state Emergency Medicaid spending contradicts assumptions about emergency care provided to recent immigrants, researchers from the University of North Carolina at Chapel Hill and the Carolinas Center for Medical Excellence have found.
Aging :: US businesses not prepared for aging workforce
More than a quarter of U.S. businesses have failed to plan for the effects of the aging American workforce, according to the results of a new national survey by researchers at Boston College.